Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 124.89 -0.64 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.53 | 52 Week High | $81.50 | |||
| Open | $126.09 | 52 Week Low | $66.33 | |||
| Day High | $127.17 | P/E | 49.56 | |||
| Day Low | $124.40 | EPS | $2.52 | |||
| Volume | 391,605 | |||||
| (NASDAQ: MIST) | Delayed: 1.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.28 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 510,198 | |||||

